Suicide In Bipolar Disorder Treatment Patients As The Foremost Cause Of Death, Reveal Researchers

,

 / 

Suicide In Bipolar Disorder Treatment Patient Is Very Common

Despite the contention that psychiatric treatment effectively reduces suicide rates in individuals with bipolar disorder (BD), recent research reveals that suicide in bipolar disorder treatment patients remains the primary cause of death among this group, even after receiving treatment.

Furthermore, contrary to the belief that those who die by suicide are often not taking their prescribed medications, the researchers say that 48% of suicide cases in this population are the result of overdosing on psychiatric drugs.

Why Suicide In Bipolar Disorder Treatment Patients Is The Primary Cause Of Death?

The study encompassed 47,018 individuals diagnosed with bipolar disorder, meticulously identified through a comprehensive Finnish nationwide registry that cataloged those who underwent extensive treatment for BD, comprising both inpatient hospitalizations and outpatient care.

The study cohort consisted of participants diagnosed with bipolar disorder between 1998 and 2018, falling within the age range of 15 to 65 years from 2004 to 2018. The median duration of follow-up was approximately eight years.

Over the course of the research, a total of 3,300 individuals (7% of the cohort) experienced mortality.

Among the various causes of death, suicide stood as the most prevalent, accounting for 740 fatalities, with 48% (353 individuals) of these suicides being attributed to overdosing on psychiatric drugs.

Additionally, the data identified 265 deaths categorized as “accidental poisonings,” of which 46% (123 deaths) were attributed to overdosing on psychiatric drugs.

Notably, there remains ambiguity regarding whether a subset of the deaths designated as “accidental poisonings” could potentially be reclassified as “suicides,” considering the tendency for societal stigma to lead to suicide cases being recorded as unintentional suicide in Bipolar Disorder treatment incidents in official records.

Read more here: Alarming Surge: Alcohol Related Deaths Among Women On The Rise, New Study Finds

The second most frequent cause of death was linked to alcohol-related factors, encompassing 595 fatalities. This category included instances of alcohol-related liver disease, alcohol poisoning, and alcohol dependence.

Furthermore, cardiovascular disease (CVD) accounted for an additional 552 deaths.

Research findings indicated that individuals under antipsychotic treatment faced a more than threefold heightened risk of succumbing to CVD, even after meticulous adjustment for confounding variables.

Notably, those utilizing a combined bipolar disorder treatments regimen of phenothiazine-type antipsychotics and antidepressants exhibited a staggering 18-fold increase in the risk of CVD-related mortality compared to the general population.

Common Causes Of Death In Bipolar Disorder Treatment

Suicide: Despite treatment, suicide remains a significant risk for individuals with bipolar disorder.

Accidental Overdose: Overdosing on psychiatric medications can occur, leading to fatal outcomes.

Cardiovascular Disease: Some medications used in bipolar disorder treatment may increase the risk of cardiovascular issues.

Substance Abuse: Co-occurring substance abuse disorders can lead to health complications and overdose.

Read more here: 3 Powerful Pointers That Will Help In Preventing Substance Abuse

Other Health Conditions: Individuals with bipolar disorder may be at an increased risk of other physical health problems, such as diabetes and obesity, which can contribute to premature death.

New Study says suicide in bipolar disorder treatment patients is the leading cause of death.
Suicide In Bipolar Disorder Treatment Patients As The Foremost Cause Of Death, Reveal Researchers

It’s important to emphasize that effective treatment, support, and monitoring can significantly reduce the risk of common causes of death in bipolar disorder treatment.

On multiple occasions, researchers have observed that individuals diagnosed with severe mental illnesses commonly experience a lifespan that is notably shorter by several decades compared to the general population.

Despite notable advancements in treatment accessibility, a recent investigation conducted in the United Kingdom highlights that this divergence in mortality rates, referred to as the “mortality gap,” continues to expand.

The present researchers propose a reorientation of focus within psychiatry towards the prevention of substance abuse and suicidal tendencies.

However, it’s important to note that they refrain from elaborating on the particular distinctions between these new priorities and the existing bipolar disorder treatments objective.


Suicide in Bipolar Disorder Treatment
Suicide In Bipolar Disorder Treatment Patients As The Foremost Cause Of Death, Reveal Researchers

— Share —

— About the Author —

Leave a Reply

Up Next

New Study Reveals Link Between Depression, Anorexia, and Gut Microbiota

Suicide in Bipolar Disorder Treatment

A recent study published in BMC Psychiatry sheds light on a potential connection between major depressive disorder (MDD), anorexia, and gut microbiota. Led by researchers at the First Hospital of Shanxi Medical University, the study suggests that individuals with both depression and anorexia exhibit distinct patterns in their gut bacteria, particularly involving the presence of a specific bacterium called Blautia.

Depression, characterized by persistent sadness and a loss of interest in daily activities, affects millions worldwide and is often accompanied by a high risk of suicide. Anorexia, marked by reduced appetite and distorted body image, commonly co-occurs with depression, complicating treatment efforts.

Gut Bacteria’s Role in Depression and Anorexia

Up Next

Beyond Chemical Imbalances: Researchers Shed Light on Social Root Causes Of Depression

Suicide in Bipolar Disorder Treatment

In a recent letter to the editor published in Molecular Psychiatry, researchers led by Joanna Moncrieff present a compelling argument challenging the conventional understanding of depression. They assert that rather than being solely attributed to chemical imbalances in the brain, and discuss the social root causes of depression.

According to Moncrieff et al., the evidence for brain differences in depression is lacking, while there is substantial support for the influence of social and environmental factors on mental health.

They argue that the circumstances of life, such as stress and adversity, play a more significant role in shaping depressive symptoms than neuro

Up Next

Study Reveals Presence of Microplastics in Human Brain: Concerns Rise Over Health Implications

Suicide in Bipolar Disorder Treatment

In a groundbreaking revelation, researchers from the University of New Mexico have discovered microplastics infiltrating human brain tissue, as reported in a study published in the journal Environment Health Perspectives. The study sheds light on the pervasive presence of microplastics in various organs of the body, including the kidneys, liver, and brain.

Eliseo Castillo, an associate professor leading the research, underscores the widespread distribution of microplastics in the environment, emphasizing their presence in water sources, food items, and even the air we breathe.

Previous studies have estimated that individuals ingest approximately five grams of microplastics weekly, equivalent to the weight of a credit card.

Up Next

Study Reveals Significant Genetic Link Between Treatment-Resistant Depression and Family History

Suicide in Bipolar Disorder Treatment

In a groundbreaking study published in the journal JAMA Psychiatry, researchers have uncovered a substantial genetic link between treatment-resistant depression (TRD) and family history.

Led by Dr. Cheng-Ta Li, a professor of medicine at the National Yang-Ming Chiao Tung University in Taipei, Taiwan, the study utilized extensive national health insurance data to investigate the transmission of TRD across generations and its association with other psychiatric disorders.

The findings of the study are particularly significant, as they shed light on the hereditary nature of TRD and its implications for early intervention and treatment.

Up Next

FDA Clears Prescription Digital Therapeutic for Adults with Major Depressive Disorder

Suicide in Bipolar Disorder Treatment

The FDA has recently cleared a groundbreaking prescription digital therapeutic, known as Rejoyn, for the treatment of major depressive disorder (MDD) symptoms in adults. This innovative therapy, developed by Otsuka Pharmaceutical Co. Ltd. in collaboration with Click Therapeutics Inc., aims to provide adjunctive care for individuals who have been prescribed antidepressants as part of clinician-managed outpatient treatment.

Rejoyn is a 6-week treatment program designed to assist individuals aged 22 years and older in regulating their emotions through a combination of clinically validated cognitive training exercises and therapeutic lessons.

The therapy utilizes digital platforms to deliver pe

Up Next

Sweet Science: How Chocolate’s Theobromine May Aid Weight Loss and Alzheimer’s Prevention

Suicide in Bipolar Disorder Treatment

A recent study conducted by researchers at Zhengzhou University in China suggests that indulging in chocolate could offer various health benefits, including weight loss assistance and Alzheimer’s prevention.

Published in the Journal of Functional Foods, the study highlights the potential of a chemical compound found in chocolate called theobromine to positively impact both the body and the brain.

Theobromine, present in cocoa beans, boasts anti-inflammatory properties and is rich in antioxidants, making it beneficial for brain health. According to scientists, this compound can protect against Alzhei

Up Next

New Study Finds High Genetic Risk for Obesity May Require Over 14,500 Daily Steps

Suicide in Bipolar Disorder Treatment

A recent study published in JAMA Network Open reveals a significant association between genetic risk for obesity and the amount of physical activity required to mitigate the risk.

Led by Dr. Evan Brittain, associate professor of medicine at Vanderbilt University Medical Center, the study analyzed data from 3,124 participants in the National Institutes of Healthโ€™s All of Us Research Program to explore the link between genetic predisposition to obesity and recommended step counts for reducing the genetic risk of developing the condition.

Findings from the study indicate that individuals with a higher genetic risk of obesity may need to undertake more physical activity